X-49030294-CCCT-C
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP3BP6_ModerateBS2
The ENST00000315869.8(TFE3):c.1589_1591delAGG(p.Glu530del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000635 in 1,201,310 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 232 hemizygotes in GnomAD. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00034 ( 0 hom., 6 hem., cov: 11)
Exomes 𝑓: 0.00066 ( 0 hom. 226 hem. )
Consequence
TFE3
ENST00000315869.8 disruptive_inframe_deletion
ENST00000315869.8 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.93
Genes affected
TFE3 (HGNC:11752): (transcription factor binding to IGHM enhancer 3) This gene encodes a basic helix-loop-helix domain-containing transcription factor that binds MUE3-type E-box sequences in the promoter of genes. The encoded protein promotes the expression of genes downstream of transforming growth factor beta (TGF-beta) signaling. This gene may be involved in chromosomal translocations in renal cell carcinomas and other cancers, resulting in the production of fusion proteins. Translocation partners include PRCC (papillary renal cell carcinoma), NONO (non-POU domain containing, octamer-binding), and ASPSCR1 (alveolar soft part sarcoma chromosome region, candidate 1), among other genes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP3
Nonframeshift variant in repetitive region in ENST00000315869.8
BP6
Variant X-49030294-CCCT-C is Benign according to our data. Variant chrX-49030294-CCCT-C is described in ClinVar as [Benign]. Clinvar id is 3176514.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAd4 at 6 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TFE3 | NM_006521.6 | c.1589_1591delAGG | p.Glu530del | disruptive_inframe_deletion | 10/10 | ENST00000315869.8 | NP_006512.2 | |
TFE3 | NM_001282142.2 | c.1274_1276delAGG | p.Glu425del | disruptive_inframe_deletion | 10/10 | NP_001269071.1 | ||
TFE3 | XM_024452432.2 | c.*219_*221delAGG | 3_prime_UTR_variant | 11/11 | XP_024308200.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TFE3 | ENST00000315869.8 | c.1589_1591delAGG | p.Glu530del | disruptive_inframe_deletion | 10/10 | 1 | NM_006521.6 | ENSP00000314129.7 | ||
TFE3 | ENST00000493583.5 | n.*1194_*1196delAGG | non_coding_transcript_exon_variant | 10/10 | 2 | ENSP00000476976.1 | ||||
TFE3 | ENST00000493583.5 | n.*1194_*1196delAGG | 3_prime_UTR_variant | 10/10 | 2 | ENSP00000476976.1 |
Frequencies
GnomAD3 genomes AF: 0.000339 AC: 37AN: 109189Hom.: 0 Cov.: 11 AF XY: 0.000190 AC XY: 6AN XY: 31509
GnomAD3 genomes
AF:
AC:
37
AN:
109189
Hom.:
Cov.:
11
AF XY:
AC XY:
6
AN XY:
31509
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000173 AC: 31AN: 178943Hom.: 0 AF XY: 0.000139 AC XY: 9AN XY: 64665
GnomAD3 exomes
AF:
AC:
31
AN:
178943
Hom.:
AF XY:
AC XY:
9
AN XY:
64665
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000665 AC: 726AN: 1092070Hom.: 0 AF XY: 0.000628 AC XY: 226AN XY: 359926
GnomAD4 exome
AF:
AC:
726
AN:
1092070
Hom.:
AF XY:
AC XY:
226
AN XY:
359926
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000339 AC: 37AN: 109240Hom.: 0 Cov.: 11 AF XY: 0.000190 AC XY: 6AN XY: 31570
GnomAD4 genome
AF:
AC:
37
AN:
109240
Hom.:
Cov.:
11
AF XY:
AC XY:
6
AN XY:
31570
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 19, 2022 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at